epigallocatechin gallate has been researched along with glucosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Huang, S; Li, R; Li, X; Liu, X; Mi, Y; Qi, G; Wang, Y | 1 |
| Du, Q; Jin, P; Liu, Z; Qin, D; Xiao, L; Xu, Y; Yin, J; Yu, C; Zheng, Y | 1 |
2 other study(ies) available for epigallocatechin gallate and glucosamine
| Article | Year |
|---|---|
(-)-Epigallocatechin-3-gallate Ameliorates Insulin Resistance and Mitochondrial Dysfunction in HepG2 Cells: Involvement of Bmal1.
Topics: AMP-Activated Protein Kinases; Animals; ARNTL Transcription Factors; Catechin; Cells, Cultured; Circadian Clocks; Glucosamine; Glucose; Hep G2 Cells; Hepatocytes; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria, Liver; Oxidative Stress | 2017 |
Enhanced Antiarthritic Efficacy by Nanoparticles of (-)-Epigallocatechin Gallate-Glucosamine-Casein.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Caseins; Catechin; Cytokines; Drug Carriers; Drug Compounding; Female; Glucosamine; Humans; Nanoparticles; Rats; Rats, Wistar | 2019 |